JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B7679 (R)-(+)-Etomoxir sodium salt

Summary: carnitine palmitoyltransferase I (CPT1) inhibitor

insoluble in H2O; insoluble in EtOH; ≥12 mg/mL
B5086 CGP 55845 hydrochloride

2 Citation

Target: GABAB Receptors

Summary: GABAB receptor antagonist

<43.87 mg/mL
A4007 MLN9708 Analogue

6 Citation

Target: Proteasome

Summary: Proteasome inhibitor

insoluble in H2O; ≥20.85 mg/mL
A4093 ITF2357 (Givinostat)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

≥23.8 mg/mL
A4065 PF-04929113 (SNX-5422)

Target: HSP90

Summary: Hsp90 inhibitor,potent and selective

≥23.85 mg/mL
A4160 A-966492

Target: PARP

Summary: PARP-1/-2 inhibitor, highly potent

≥32.4 mg/mL
A4117 AT9283

Summary: Aurora kinase/JAK inhibitor

insoluble in H2O; ≥19.05 mg/mL
A4217 QNZ (EVP4593)

6 Citation

Summary: Potent NF-κB inhibitor
A4305 WY-14643 (Pirinixic Acid)

10 Citation

Target: PPAR

Summary: PPARα agonist,selective and highly potent

insoluble in H2O; ≥16.2 mg/mL
A4327 Tadalafil

Target: Phosphodiesterases (PDEs)

Summary: PDE5 inhibitor

insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL